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Background: Both Plasmodium vivax and Plasmodium falciparum are prevalent in Pakistan, yet up-to-date data on
the epidemiology of malaria in Pakistan are not available. This study was undertaken to determine the current
prevalence and distribution of Plasmodium species across the country.
Methods: A malariometric population survey was conducted in 2011 using blood samples collected from 801 febrile
patients of all ages in four provinces and the capital city of Islamabad. Microscopically confirmed Plasmodium-positive
blood samples were reconfirmed by polymerase chain reaction (PCR). Confirmed parasite-positive samples were
subjected to species-specific PCR capable of detecting four species of human malaria.
Results: Of the 707 PCR-positive samples, 128 (18%) were P. falciparum, 536 (76%) were P. vivax, and 43 (6%) were mixed
P. falciparum and P. vivax. Ninety-four microscopy-positive samples were PCR-negative, and Plasmodium malariae and
Plasmodium ovale were not detected. Prevalence of P. vivax ranged from 2.4% in Punjab Province to 10.8% in Sindh
Province and prevalence of P. falciparum ranged from 0.1% in Islamabad to 3.8% in Balochistan.
Conclusions: Plasmodium infections in Pakistan are largely attributed to P. vivax but P. falciparum and mixed species
infections are also prevalent. In addition, regional variation in the prevalence and species composition of malaria is high.
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Ninety-five million of Pakistan's 161 million people,
roughly 60% of Pakistan’s population, live in malaria-
endemic regions [1,2]. After eradication efforts in the
1960s, malaria surged back to an epidemic level in the
1970s. In recent years, an uptick in malaria can be partially
attributed to floods that affected approximately 20 million
people in over 60 districts [2]. Despite a well-established
malaria control programme, 500,000 malaria infections
and 50,000 malaria-attributable deaths occur each year in
Pakistan [3], with approximately 37% of cases estimated to
occur in regions along the borders with Afghanistan and
Iran [4].
Pakistan’s climate ranges from tropical to temperate
with dry conditions along the southern coast [5], and* Correspondence: cplowe@medicine.umaryland.edu
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reproduction in any medium, provided the orelevation ranges from sea level to nearly 9,000 meters [6].
Plasmodium vivax (responsible for approximately 64% of
infections) and Plasmodium falciparum (causing 36% of
infections) are the two prevalent Plasmodium species in
Pakistan [7], and malaria is primarily found in the prov-
inces of Khyber Pakhtunkhwa, Balochistan, Sindh and the
Federally Administered Tribal Areas [8]. Malaria transmis-
sion is considered to be unstable, with major P. vivax
transmission peaking from June to September and again in
April to June, when relapses of infections acquired the pre-
vious season are observed [9]. The major transmission
period for P. falciparum in Pakistan is between August and
December [9].
Although the majority of malaria cases in Pakistan
is caused by P. vivax, trends in the past few decades
have indicated that P. falciparum infection is on the
rise. The World Health Organization (WHO) reported
that in Pakistan the proportion of malaria infections at-
tributed to P. falciparum rose from 34% in 1987 to 54%
in 1990 [9,10]. The frequency of P. falciparum amongLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2006 in the city of Quetta in Balochistan province and in
Jhangara city of Sindh province [11,12]. In 2010, 73,857
(31%) of 240,591 total reported malaria cases in Pakistan
were P. falciparum [13].
The rise of P. falciparum in parts of Pakistan may be
partially attributable to failed treatment of chloroquine-
resistant infections [14]. Chloroquine resistance in P. fal-
ciparum was reported for the first time from Pakistan in
1984 and later confirmed as widespread [13,15-17]. A re-
cent study found that 90% of P. falciparum samples col-
lected in the provinces of Balochistan and Sindh carried
the pfcrt 76 T allele responsible for conferring chloroquine
resistance [18]. Although chloroquine is recommended
only for treatment of P. vivax, P. falciparum infections are
often treated with chloroquine, as presumptive diagnosis
or empiric treatment is usually based on clinical symptoms
in resource-limited countries like Pakistan [19].
The heavy influx and continued presence of refugees
from Afghanistan, where P. falciparum is more preva-
lent, may also contribute to the increase of P. falciparum
in Pakistan [20-22] potentiating clinical trials of falcip-
arum malaria in the refugee populations in regions such as













Figure 1 Sample sites and distribution of Plasmodium species acrossthat refugees have low immunity and are more suscep-
tible to malaria in Pakistan than are permanent residents
[10,24,25]. These factors may lead to increased disease
and transmission in the refugee population. Monitoring
the distribution and burden of Plasmodium species in
Pakistan as changes occur in both human and parasite
populations is necessary to ensure appropriate treatment,
particularly in situations where diagnosis by microscopy
or species-specific rapid diagnostic tests is not available.
A handful of malaria epidemiological studies have been
conducted in parts of Pakistan, but the assessment of
the malaria burden on a national scale has been hin-
dered by the lack of data from many areas [26]. One
report of malariometric surveys conducted from 2005
to 2009 found both spatial and temporal variation in
malaria endemicity. Malaria prevalence was highest in
the Federally Administered Tribal Areas, followed by
Balochistan and Khyber Pakhtunkhwa Provinces [4]
(Figure 1), and over the five-year period malaria inci-
dence was highest in 2009 [4]. The aim of this study was
to provide a current report on malaria in Pakistan. Sur-
veys were conducted in 2011 in 14 sites across four prov-
inces as well as in the capital city of Islamabad to determine













Pakistan, 2011. KPK: Khyber Pakhtunkhwa province.
Table 1 Microscopic and PCR-based diagnosis of
Plasmodium infections in clinical isolates
Species Microscopy PCR analysis
Plasmodium falciparum 138 (17%) 128 (18%)
Plasmodium vivax 656 (82%) 536 (76%)
Mixed (P. falciparum + P. vivax) 7 (1%) 43 (6%)
Plasmodium malariae 0 0
Plasmodium ovale 0 0
Negative 0 94 (12%)
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Methods
Government and private hospitals in 25 cities from four
provinces with the highest burden of malaria representing
all four provinces (Khyber Pakhtunkhwa province, Sindh
province, Balochistan province and Punjab province) and a
hospital in the capital city, Islamabad, were invited to par-
ticipate in the molecular survey. Although the Federally
Administered Tribal Areas have among the highest bur-
dens of malaria in the country, they were excluded from
this study because political instability and violence [27]
make it difficult to establish sample collection. Of the facil-
ities that were contacted, hospitals in 14 cities shared sam-
ples and were included in this study: Islamabad (Capital),
Peshawar, Thall, Bannu and Hangu (Khyber Pakhtunkhwa
province), Karachi and Hyderabad (Sindh province), Zhob
and Quetta (Balochistan province), Rawalpindi, Bhakhar,
Mainwali, Lahore and Muzaffargarhar (Punjab province)
(Figure 1). Samples were collected during the peak malaria
transmission season, between April and October 2011,
at all sites. The study included patients of all age groups
with malarial signs and symptoms (fever, chills, headache,
sweats, fatigue, nausea and vomiting). The study was ap-
proved by the Institutional Review Board of Quaid-i-Azam
University, Pakistan.
For patients giving informed consent, 3 ml of intraven-
ous blood was drawn into an EDTA tube by venepunc-
ture and limited demographic information (patient age
and gender) was recorded. Thick and thin films were
stained with 10% Giemsa solution and examined at 100×
under oil immersion. Smears were examined by a la-
boratory technician or technologist trained in malaria
diagnosis according to WHO guidelines [28]. About 50 μl
of each blood sample from 801 malaria microscopy-
positive and 30 smear-negative samples was also applied to
Whatman 3MM filter paper. Blood spots were air-dried
overnight and stored in individual plastic bags with desic-
cant at room temperature. Remaining blood samples were
stored at −80°C on site at each hospital.
Molecular analysis was conducted at the University of
Maryland School of Medicine, Baltimore, MD, USA.
Parasite DNA was extracted from filter papers using the
Qiagen DNA extraction kit (Qiagen, Valencia, CA, USA).
Plasmodium species (P. vivax, P. falciparum, Plasmodium
ovale and Plasmodium malariae) were detected by nested
polymerase chain reaction (PCR) amplification of the small
sub-unit ribosomal ribonucleic acid (ssrRNA) genes using
the primers and thermal cycler conditions as described
[29,30]. The amplified PCR products were visualized by 2–
2.5% agarose gel electrophoresis, stained with ethidium
bromide and visualized using the Bio-Rad gel doc system
(Bio-Rad Laboratories, Hercules, CA, USA).Results
A total of 801 microscopy-positive samples was ampli-
fied by PCR along with positive and negative controls.
By microscopy, 17% (n = 138) were identified as P. falcip-
arum, 82% (n = 656) as P. vivax and 0.9% (n = 7) as mixed
(Table 1). Nested PCR identified 18% (n = 128) as P. falcip-
arum, 76% (n = 536) as P. vivax, 6% (n = 43) as mixed
P. falciparum/P. vivax, and 94 samples as parasite-negative.
P. malariae and P. ovale were not detected in any samples,
and 27 of 30 microscopy-negative samples were parasite-
positive by PCR.
Discrepancies between PCR and microscopy were identi-
fied for 36 mixed-species samples by PCR (10 character-
ized as P. falciparum monoinfection and 26 as P. vivax
monoinfection by microscopy) and 94 parasite-negative
samples by PCR (characterized as P. vivax (82), P. falcip-
arum (11) and mixed species infection (1) by microscopy).
Slides were not available for re-examination in the case of
discrepancies between microscopy and PCR, but PCR was
repeated and results confirmed for all 130 samples.
Cohen’s kappa statistic to measure concordance be-
tween microscopy and PCR indicated that overall agree-
ment for presence or absence of Plasmodium infection
was high (kappa = 0.89), although agreement on mixed
species infections was low (kappa = 0.49) due to the identi-
fication of a number of mixed species infections by PCR as
either P. vivax or P. falciparum monoinfections by micros-
copy. Agreement on diagnosis as P. falciparum was high
(kappa = 0.94) while agreement for P. vivax was slightly
lower (kappa = 0.82), owing to the classification of 120
samples as P. vivax-positive by microscopy that did not
have a detectable infection by PCR.
The age of subjects ranged from two months to
75 years, with a median of 24 years (Table 2). Age did not
vary significantly by province. Overall, nearly two-thirds
(64%) of the subjects were male. Males predominated in all
study areas, ranging from 55% of subjects in Balochistan to
72% of subjects in Islamabad.
Of the 801 microscopy-positive samples, 707 PCR-
positive malaria cases were detected at all sites (Table 3).
Khyber Pakhtunkhwa had the highest number of cases
at 325, followed by Punjab with 157 cases. The overall






Age in years median
(Range)
Balochistan 52 (55%) 42 (45%) 29 (4 to 70)
Islamabad 62 (72%) 23 (28%) 26 (3 to 75)
KPK 231 (63%) 133 (37%) 22 (0.3 to 75)
Punjab 126 (64%) 71 (36%) 24 (0.4 to 65)
Sindh 38 (62%) 23 (38%) 28 (0.3 to 65)
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seeking patients with suspected malaria was 6.6%: 5%
P. vivax, 1.2% P. falciparum and 0.4% mixed P.vivax/
P. falciparum infections. Balochistan, Sindh and Khyber
Pakhtunkhwa provinces exhibited the highest prevalence
of total Plasmodium infections, at 12.4, 11.1 and 10.8%, re-
spectively (Table 3). Malaria prevalence in Punjab ranged
from 1.7% in Lahore to 5.5% in Bhakkar cities. The capital
city of Islamabad had an overall malaria prevalence of 4.6%
(Table 3).
P. vivax was the predominant malaria species in most
regions of the survey. However, P. falciparum was found
in the majority of Plasmodium infections in Quetta city
of Balochistan province, and Muzaffarghar of PunjabTable 3 Prevalence (%) of Plasmodium infection among indiv
by province and city
Province City Suspected cases P. viva




















*Prevalence was calculated by dividing the number of PCR-positive cases by the nuprovince and in about one-third to one-half of all malaria
infections in three other sites: Mainwali in Punjab, and
Hangu and Bannu near Khyber Pakhtunkhwa’s Afghan
border (Figure 1). Balochistan and Khyber Pakhtunkhwa
provinces had the highest proportion of mixed P. falcip-
arum/P. vivax infections, at 10 and 8%, respectively. P. fal-
ciparum malaria was virtually absent from the other three
Punjabi sites, as well as from both cities in Sindh prov-
ince and from Islamabad city (Table 4).
Discussion
Malaria continues to be a serious public health problem in
Pakistan. In 2008, 2.6 million malaria cases were reported
nationwide with a mortality rate of 50,000 per year
[13,31-33]. Over one million microscopy-confirmed mal-
aria cases were reported from the Eastern Mediterranean
region in 2010, 22% of which came from Pakistan [13]. It
has been difficult to accurately estimate the prevalence of
Plasmodium infection in Pakistan, largely because the di-
versity in prevalence and species distribution of malaria-
causing parasites in different parts of the country has not
been fully described.
This survey was conducted to provide up-to-date in-
formation on malaria prevalence throughout Pakistan.
Because samples were collected from patients presentingiduals presenting with symptoms consistent with malaria,
Prevalence*
x P. falciparum Mixed species All species











%) 25 (3.8%) 8 (1.2%) 82(12.4%)
7.9% 1.4% 10.4%
0.8% 1.1% 13.9%
.8%) 1 (0.2%) 1 (0.2%) 60 (11.1%)
0.0% 0.0% 12.1%
0.3% 0.3% 10.3%
%) 2 (0.1%) 0 (0.0%) 83 (4.6%)
0.1% 0.0% 4.6%
1.2% 0.4% 6.6%
mber of suspected cases.
Table 4 Number of samples PCR-positive for Plasmodium
infection, by province and city
PCR positive samples*
Province City P. vivax P. falciparum Mixed species
Khyber Pakhtunkhwa 234 (72%) 65 (20%) 26 (8%)
Bannu 69 29 10
Hangu 30 14 5
Peshawar 43 3 1
Thall 92 19 10
Punjab 114 (73%) 35 (22%) 8 (5%)
Bhakkar 35 1 0
Lahore 16 0 1
Mainwali 31 24 4
Muzaffarghar 8 10 3
Rawalpindi 24 0 0
Balochistan 49 (60%) 25 (30%) 8 (10%)
Quetta 3 22 4
Zhob 46 3 4
Sindh 58 (96%) 1 (2%) 1 (2)%
Hyderabad 29 0 0
Karachi 29 1 1
Capital 81 (98%) 2 (2%) 0%
Islamabad 81 2 0
All 536 (76%) 128 (18%) 43 (6%)
* Percentages indicate the proportion of PCR-positive samples for each species.
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gional variation in treatment-seeking behaviour and ac-
cess to treatment centres. Unfortunately, information on
treatments taken prior to diagnosis was not collected
and could not be included in this analysis. In addition,
the timing of sample collection at each site may have co-
incided with varying levels of species-specific malaria
transmission. All patients were sampled within the trans-
mission season at each site, but during months that may
have correlated with the presence of a particular species:
P. vivax peaks between April and September while P. fal-
ciparum peaks between August and December [2,34-36].
Regional variations in peak times also occur, with a study
in the hilly region of Balochistan reporting highest P. vivax
infection and lowest P. falciparum infection in March and
the opposite pattern in October [37]. These effects should
be taken into account when assessing relatively small
reported differences in the prevalence of malaria and in
the proportion of P. vivax and P. falciparum cases among
regions. Despite these limitations, the data presented
here contribute to a more comprehensive and current
characterization of malaria in Pakistan than has previ-
ously been available.
The predominance of malaria infection in males in
their twenties has been observed in previous studies inthis region [37,38]. Some hypotheses for the dispropor-
tionate number of male malaria patients include in-
creased exposure because males are more likely to work
outside and not be as well-covered as females, leading to
an increased number of infected Anopheles bites, or that
females may have diminished access to health care facil-
ities and may not seek medical attention as frequently as
males [26].
This survey indicated that the highest prevalence of
malaria is found in Balochistan, followed by Sindh and
Khyber Pakhtunkhwa, with lower prevalence in Punjab
and the city of Islamabad. Similarly, the Malaria Case
Management Desk Guide reported in 2007 that Sindh and
Balochistan provinces contributed the majority of mal-
aria cases in Pakistan, followed by Khyber Pakhtunkhwa
province and the Federally Administered Tribal Areas,
with the fewest cases reported in Punjab province [34].
This study also confirmed previous findings that P. vivax
and P. falciparum are the two major Plasmodium species
found in Pakistan, with P. vivax predominating in most
regions [13,33,39].
In addition to the highest malaria prevalence in Pakistan,
Balochistan also had the highest proportion of P. falcip-
arum cases, due to the predominance of falciparum mal-
aria in one of its districts, Quetta. Other studies have also
reported a high prevalence of P. falciparum in this region,
including in Quetta itself [39,40], and the cities of Zhob
[37], East Balochistan [39], and Khuzdar in Balochistan
province [41]. Although generally higher than in other re-
gions of Pakistan, estimates of the proportion of P. falcip-
arum infections within Balochistan province vary widely by
location, from 15% in Zhob to nearly 90% in Quetta, indi-
cating that geographic variation among districts is high.
The two sites in Sindh, Karachi and Hyderabad, had an
overall malaria prevalence of 11%, with very few P. falcip-
arum or mixed species infections. In contrast, previous
studies have shown that approximately one-quarter to one-
half of malaria cases were attributed to P. falciparum in
these cities [42-44]. This difference may be attributable
to the narrow sampling window in this province. The
majority of samples was collected in April in Sindh, while
previous observations indicate that peak infection of
P. falciparum does not occur until later in the year [32].
Thall, Bannu and Hangu in Khyber Pakhtunkhwa prov-
ince all showed high prevalence of malaria and a high
proportion of cases attributed to P. falciparum. Other
studies in this region have found a relatively high number
of cases and varying levels of P. falciparum, from 16% of
malaria cases in Buner [42] to 25% in Abbottabad and
Bannu [33,45] to over 90% of cases in Manshera [46].
Cross-border migration may have contributed to the main-
tenance or surge of malaria in this region. Between 1979
and 1982, refugees from Afghanistan fled across the border
into Khyber Pakhtunkhwa and Balochistan provinces [47].
Khattak et al. Malaria Journal 2013, 12:297 Page 6 of 8
http://www.malariajournal.com/content/12/1/297This influx of a potentially more malaria-susceptible popu-
lation may have overwhelmed the public health system
[24], leading to greater disease. The movement of Afghan
refugees into Baluchestan province, Iran, was estimated to
result in a 24-36% increase in the number of malaria cases
[48]. Recent internal displacement may also be contribut-
ing to the high prevalence of malaria. In 2009, inhabitants
of several districts in the Federally Administered Tribal
Areas and Khyber Pakhtunkhwa fled war conditions to set-
tle in adjoining districts [49,50]. These large movements of
vulnerable populations may have altered the distribution of
malaria and malaria-susceptible people in the country [50],
contributing to epidemics such as that reported in a Paki-
stani refugee camp in 2003 where incidence was as high as
100 cases per 1,000 persons per year [51].
Punjab province and the city of Islamabad had little
malaria in comparison with other parts of the country.
The prevalence of malaria in Islamabad has not previ-
ously been reported, but other studies in Punjab province
reported similar results, with a microscopy-positive malaria
prevalence of 2.4% in house-to-house surveys in 1999 [52]
and low annual incidence, with less than one case per
10,000 per year between 2004 and 2009 [4]. Two contrib-
utors to the low level of malaria in Punjab have been sug-
gested. Environmental changes resulting in waterlogging
and salinization may have reduced suitable habitats for
the more efficient vector, Anopheles culicifacies, while in-
creasing breeding sites for the salt tolerant and less effi-
cient vector, Anopheles stephensi [4]. Additionally, overall
socio-economic conditions and the public health infra-
structure are comparatively better in Punjab than in the
rest of the country, and may play a role in more effect-
ively controlling malaria [52].
Agreement between PCR and microscopy was high
overall, but discrepancies were detected in samples that
were microscopy-positive and PCR negative for Plasmo-
dium and for samples that were P. falciparum or P. vivax
monoinfections by microscopy but mixed species infec-
tions by PCR. Confirmation of PCR results in repeated as-
says suggests that the error likely lies in diagnosis by
microscopy. Similar results have been reported in Pakistan
[33] where nearly 15% of samples positive by microscopy
were parasite-negative by PCR and in a 2007 study in
Afghanistan, Iran, and Pakistan where 6.5, 2.2 and 23.5% of
microscopically diagnosed P. vivax mono-infections, re-
spectively, were mixed species by PCR [53]. The propensity
to report febrile patients as parasite-positive has been
reported [54], and factors influencing accuracy of micro-
scopic diagnosis, including use of contaminated reusable
microscope slides, staining artifacts, lack of microscopic
expertise, and lack of quality assurance [55,56] have been
well-documented.
It has been estimated that in countries where P. vivax is
predominant, over one-third of patients presenting withacute P. vivax also harbour cryptic P. falciparum [57]. Mis-
diagnosis of mixed species infections can result in im-
proper or incomplete treatment, particularly in countries
like Pakistan, where chloroquine is used to treat P. vivax
but is known to be ineffective against P. falciparum.
Household surveys conducted in 2010 indicating that
80% of patients with suspected P. falciparum malaria
(confirmed or unconfirmed) received chloroquine, 14% re-
ceived an artemisinin-based combination therapy (ACT)
and 16% were not treated with any anti-malarial [32]. As-
sessment of the quality of malaria microscopy in Pakistan
may aid in identifying areas for improved diagnosis and
treatment, particularly in regions endemic for both Plas-
modium species.
Conclusions
Pakistan faces several challenges in the management and
control of malaria, including misdiagnosis, lack of diag-
nostic facilities, use of presumptive treatments and un-
availability of ACT [58-60]. Information on the burden
and species distribution of malaria is critical for guiding
national and provincial efforts in diagnosis and effective
treatment. The results of this study indicate that malaria
control efforts should be focused on Khyber-Pakhtunkhwa,
Balochistan and Sindh provinces, where malaria prevalence
is highest, with an emphasis on improving species diagno-
sis and ACT availability for treatment of P. falciparum in
Quetta city of Balochistan, parts of Khyber Pakhtunkhwa,
and Punjab province.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AAK designed the study, carried out the laboratory experiments, and
conducted data analysis. AAK and MV drafted the manuscript. MFN, HSS and
AY participated in sample and data collection and microscopy. KS aided in
laboratory experimental design and execution. MV, LK, SAM and CVP
provided guidance and coordination for study design laboratory analyses
and data analysis, and edited and revised the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
The authors thank the study participants for their involvement in the study.
The authors also thank Matthew Adams, Malathi Vadla and Sudhaunshu
Joshi at the University of Maryland for their technical assistance and
Muhammad Shahid, Islamil Jalil, Ifthikhar Ahmed, Adeel Riaz and Noor
Rehman in Pakistan for helping in sample collection. This work was
supported by a grant from the Higher Education Commission of Pakistan in
support of AAK's PhD studies at Quaid-i-Azam University, Islamabad, Pakistan,
and was supported in part by the Howard Hughes Medical Institute / Center
for Vaccine Development at the University of Maryland School of Medicine,
Baltimore, MD, USA.
Author details
1Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam
University, Islamabad, Pakistan. 2Howard Hughes Medical Institute/Center for
Vaccine Development, University of Maryland School of Medicine, Baltimore,
MD, USA. 3WorldWide Antimalarial Resistance Network Molecular Module,
University of Maryland School of Medicine, Baltimore, MD, USA. 4King
Edward Medical University, Lahore, Pakistan. 5Department of Biochemistry
and Molecular Biology, University of Gujrat, Gijrat, Pakistan.
Khattak et al. Malaria Journal 2013, 12:297 Page 7 of 8
http://www.malariajournal.com/content/12/1/297Received: 30 May 2013 Accepted: 26 August 2013
Published: 28 August 2013
References
1. WHO: WHO Eastern Mediterranean regional office. Cairo: World Health
Organization; 2013.
2. Williams O, Meek S: Malaria: country profiles. London: Department of
International Development; 2011.
3. Mukhtar M: Killer number one: the fight against malaria: malaria strategy lags
behind the global goals, Humanitarian news and analysis a service of the UN
Office for the Coordination of Humanitarian Affairs. Nairobi: IRIN; 2006.
4. Kakar Q, Khan MA, Bile KM: Malaria control in Pakistan: new tools at hand
but challenging epidemiological realities. East Mediterr Health J 2010,
16(Suppl):S54–S60.
5. Federal Research Division: Country profile: Pakistan. Library of Congress; 2012.
6. Land surface elevation extremes by country. http://en.wikipedia.org/wiki/
List_of_elevation_extremes_by_country.
7. WHO: World malaria report 2012. Geneva; 2012.
8. Kakar Q, Khan MA, Bile KM: Malaria control in Pakistan: new tools at hand
but challenging epidemiological realities. East Mediterr Health J 2010,
16(Suppl):S54–S60.
9. Bouma MJ, Dye C, van der Kaay HJ: Falciparum malaria and climate
change in the northwest frontier province of Pakistan. Am J Trop Med
Hyg 1996, 55:131–137.
10. Bouma MJ, Parvez SD, Nesbit R, Winkler AM: Malaria control using
permethrin applied to tents of nomadic Afghan refugees in northern
Pakistan. Bull World Health Organ 1996, 74:413–421.
11. Rab MA, Freeman TW, Durrani N, De PD, Rowland MW: Resistance of
Plasmodium falciparum malaria to chloroquine is widespread in eastern
Afghanistan. Ann Trop Med Parasitol 2001, 95:41–46.
12. Durrani AB, Durrani IU, Abbas N, Jabeen M: Epidemiology of cerebral
malaria and its mortality. J Pak Med Assoc 1997, 47:213–215.
13. WHO: World malaria report. Geneva: World Health Organization; 2011.
14. Nizamani MA, Kalar NA, Khushk IA: Burden of malaria in Sindh, Pakistan: a
two years surveillance report. J Liaquat University of Med Health Sci 2006,
5:762–83.
15. Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Martensson A: Prevalence
of resistance associated polymorphisms in Plasmodium falciparum field
isolates from southern Pakistan. Malar J 2011, 10:18.
16. Rana MS, Tanveer A: Chloroquine resistance and Plasmodium falciparum
in Punjab, Pakistan during 2000–2001. Southeast Asian J Trop Med Public
Health 2004, 35:288–291.
17. Robinson DS, Hadley-Brown M, Ejele OA, Robinson PS: Chloroquine-resistant
malaria in Pakistan. Lancet 1984, 2:987.
18. Rawasia WF, Sridaran S, Patel JC, Abdallah J, Ghanchi NK, Barnwell JW,
Escalante AA, Udhayakumar V, Beg MA: Genetic backgrounds of the
Plasmodium falciparum chloroquine resistant transporter (pfcrt) alleles in
Pakistan. Infect Genet Evol 2012, 12:278–281.
19. Parikh R, Amole I, Tarpley M, Gbadero D, Davidson M, Vermund SH: Cost
comparison of microscopy vs. empiric treatment for malaria in
Southwestern Nigeria: a prospective study. Malar J 2010, 9:371.
20. Malik IA, Iqbal I, Malik S: A study of cerebral malaria at Multan.
Pakistan Pediatric J 1996, 20:175–180.
21. Murtaza G, Memon IA, Noorani AK: Malaria prevalence in Sindh. Med Channel
2004, 10:41–42.
22. Sheikh AS, Sheikh AA, Sheikh NS, Paracha SM: Endemicity of malaria in
Quetta. Pakistan J Med Res 2005, 44:41–45.
23. Howard N, Durrani N, Sanda S, Beshir K, Hallett R, Rowland M: Clinical trial
of extended-dose chloroquine for treatment of resistant falciparum
malaria among Afghan refugees in Pakistan. Malar J 2011, 10:171.
24. Suleman M: Malaria in Afghan refugees in Pakistan. Trans R Soc Trop Med
Hyg 1988, 82:44–47.
25. De ZJ, Mujtaba SM, Shah IH: Malaria control and long-term periodicity of
the disease in Pakistan. Trans R Soc Trop Med Hyg 1980, 74:624–632.
26. Khan HU, Khattak AM, Khan MH, Mahsud IU, Shah SH: A study of
prevalence of malaria in adult population of D. I. Khan, Pakistan.
Biomedica 2006, 22:99–104.
27. Nawaz S: FATA—A most dangerous place. D.C: Washington; 2009.
28. Asif SA: Departmental audit of malaria control programme 2001–2005
north west frontier province (NWFP). J Ayub Med Coll Abbottabad 2008,
20:98–102.29. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, De Rosario VE,
Thaithong S, Brown KN: High sensitivity of detection of human malaria
parasites by the use of nested polymerase chain reaction. Mol Biochem
Parasitol 1993, 61:315–320.
30. Singh N, Shukla MM, Sharma VP: Epidemiology of malaria in pregnancy in
central India. Bull World Health Organ 1999, 77:567–572.
31. Qayum M, Zahur H, Ahmad N, Ilyas M, Khan A, Khan S: SPHERE-based
assessment of knowledge and preventive measures related to malaria
among the displaced population of Jalozai, Pakistan. J Pak Med Assoc
2012, 62:344–346.
32. MOH: Pakistan national strategic plan for malaria control 2010 – 2015.
Islamabad: Ministry of Health; 2010.
33. Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G: Prevalence of
antimalarial drug resistance mutations in Plasmodium vivax and
P. falciparum from a malaria-endemic area of Pakistan. Am J Trop Med
Hyg 2009, 81:525–528.
34. DMC: Malaria case management desk guide for clinicians and health care
providers. Islamabad: Directorate of Malaria Control; 2007.
35. Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G: Genetic structure of
Plasmodium vivax and Plasmodium falciparum in the Bannu district of
Pakistan. Malar J 2010, 9:112.
36. Mukhtar M: Guidelines for antivector interventions for monsoon season.
Pakistan: Directorate of Malaria Control, Ministry of Health; 2009:1–14.
37. Yasinzai MI, Kakarsulemankhel JK: Incidence of human malaria infection in
northern hilly region of Balochistan, adjoining with NWFP, Pakistan:
district Zhob. Pak J Biol Sci 2008, 11:1620–1624.
38. Yasinzai MI, Kakarsulemankhel JK: Prevalence of human malaria infection
in Pakistani areas bordering with Iran. J Pak Med Assoc 2013, 63:313–316.
39. Yasinzai MI, Kakarsulemankhel JK: Prevalence of human malaria infection
in bordering areas of East Balochistan, adjoining with Punjab: Loralai
and Musakhel. J Pak Med Assoc 2009, 59:132–135.
40. Yasinzai MI, Kakarsulemankhel JK: Frequency of human malaria infection in
south east area of Balochistan, District Lasdella. Pak J Biol Sci 2012,
28:167–170.
41. Farooq MA, Salamat A, Iqbal MA: Malaria–an experience at CMH Khuzdar
(Balochistan). J Coll Physicians Surg Pak 2008, 18:257–258.
42. Noor M, Akbar H: Prevalence of malaria in general populationof distric
Buner. J Pak Inst Med Sci 2003, 17:75–80.
43. Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R,
Smego R Jr: Comparative features and outcomes of malaria at a tertiary
care hospital in Karachi, Pakistan. Int J Infect Dis 2008, 12:37–42.
44. Hayyat AS, Memon F, Shaikh N, Fatah Dero AF: Incidence and pattern of
malarial infection at a tertiary care Hospital of Hyderabad. World J Med
Sci 2009, 4:9–12.
45. Idris M, Sarwar J, Fareed J: Pattern of malarial infection diagnosed at Ayub
teaching hospital Abbottabad. J Ayub Med Coll Abbottabad 2007, 19:35–36.
46. Jalal UD, Khan SA, Ally SH: Malaria in children: study of 160 cases at a
private clinic in Mansehra. J Ayub Med Coll Abbottabad 2006, 18:44–45.
47. WHO: World malaria situation in 1990. Bull World Health Organ 1992,
70:801–813.
48. Basseri HR, Raeisi A, Holakouie K, Shanadeh K: Malaria prevention among
Afghani refugees in a malarious area, southeastern Iran. Bull Soc Pathol
Exot 2010, 103:340–345.
49. Kakar Q: Guidelines for anti-vector interventions in complex emergencies/IDPs.
Islamabad: Directorate of Malaria Control, Ministry of Health; 2009.
50. WFP: U.S Global Health Policy. California: U.S. Global Health Programs; 2009.
51. Leslie T, Kaur H, Mohammed N, Kolaczinski K, Ord RL, Rowland M: Epidemic
of Plasmodium falciparum malaria involving substandard antimalarial
drugs, Pakistan, 2003. Emerg Infect Dis 2009, 15:1753–1759.
52. Herrel N, Amerasinghe FP, Ensink J, Mukhtar M, van der Hoek W, Konradsen F:
Adult anopheline ecology and malaria transmission in irrigated areas of
South Punjab, Pakistan. Med Vet Entomol 2004, 18:141–152.
53. Zakeri S, Kakar Q, Ghasemi F, Raeisi A, Butt W, Safi N, Afsharpad M, Memon MS,
Gholizadeh S, Salehi M, Atta H, Zamani G, Djadid ND: Detection of mixed
Plasmodium falciparum & P. vivax infections by nested-PCR in Pakistan,
Iran & Afghanistan. Indian J Med Res 2010, 132:31–35.
54. Ngasala B, Mubi M, Warsame M, Petzold MG, Massele AY, Gustafsson LL,
Tomson G, Premji Z, Bjorkman A: Impact of training in clinical and
microscopy diagnosis of childhood malaria on antimalarial drug
prescription and health outcome at primary health care level in
Tanzania: a randomized controlled trial. Malar J 2008, 7:199.
Khattak et al. Malaria Journal 2013, 12:297 Page 8 of 8
http://www.malariajournal.com/content/12/1/29755. Makler MT, Palmer CJ, Ager AL: A review of practical techniques for the
diagnosis of malaria. Ann Trop Med Parasitol 1998, 92:419–433.
56. Moody A: Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev
2002, 15:66–78.
57. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T: High rate
of Plasmodium vivax relapse following treatment of falciparum malaria in
Thailand. Lancet 1987, 2:1052–1055.
58. GFATM: Round 7 funding application: Pakistan 2007. Washington, DC: The
Global Fund; 2007.
59. SoSec Consulting Services: 19 districts Pakistan (draft final report). Islamabad:
Islamabad SoSec Consulting Services; 2009.
60. Rowland M, Rab MA, Freeman T, Durrani N, Rehman N: Afghan refugees
and the temporal and spatial distribution of malaria in Pakistan. Soc Sci
Med 2002, 55:2061–2072.
doi:10.1186/1475-2875-12-297
Cite this article as: Khattak et al.: Prevalence and distribution of human
Plasmodium infection in Pakistan. Malaria Journal 2013 12:297.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
